Gilead Sciences and WuXi Partner for a Dedicated Analytical and Stability Testing Facility

WuXi Gilead opening

We are pleased to announce that we have entered into a strategic partnership with Gilead Sciences to conduct analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products.  WuXi’s Lab Testing Division (LTD) will equip and operate a dedicated, fully cGMP-compliant analytical testing facility in Shanghai with dedicated staff.   The opening of this analytical and stability testing center is an important milestone in the ongoing long-term relationship between Gilead and WuXi.  We are determined to enable our innovative partners like Gilead through our open-access R&D platform, and we are honored to help advance some of the most innovative medicines faster to patients.


Related Links:

  1. WuXi to Be Exclusive Supplier of Laboratory Testing Services to Lee’s Pharm
  2. WuXi Launches Medical Device Testing Services in China

Subscribe to WXPress

Receive our newsletter and information on upcoming events.